Skip to main content
Caplight Logo









Yantai Lannacheng Biotechnology Co., Ltd.

Yantai Lannacheng Biotechnology Co., Ltd.

Private
YantaiHealthcare & Life Scienceshttps://lannacheng.com

Last Round

Series C

Jul 18, 2025

Est. Valuation

$459.14M

Total Funding Raised

$164.52M

Company Overview

Yantai Lannacheng Biotechnology Co., Ltd. is a clinical-stage biotechnology company that develops radiopharmaceuticals for integrated cancer diagnosis and therapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical Imaging

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

radiopharmaceuticalstheranosticsnuclear medicinetargeted radiotherapyprecision medicineoncologydrug discoverybiopharmaceuticalRDCradiopharmaceutical drug conjugatesAI-assisted drug designPSMA-targeted therapyFAP-targeted therapyisotope supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Yantai Lannacheng Biotechnology Co., Ltd. Comparables

Compare Yantai Lannacheng Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

Yantai Lannacheng Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Full-Life Technologies
85%
Suzhou SmartNuclide Biopharmaceutical Co., Ltd.
82%
Chengdu NewRT Medical Technology
82%

Yantai Lannacheng Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJul 18, 2025
Series CFeb 14, 2025
Series B ExtensionApr 25, 2024
Series BJun 27, 2023
Series AJun 8, 2022

Yantai Lannacheng Biotechnology Co., Ltd. Investors

Notable investors and investment history

Yantai Lannacheng Biotechnology Co., Ltd. investors
InvestorRounds
China CindaSeries C
烟台财金集团Series B Extension
山东省新动能基金管理有限公司Series C
Real Power CapitalSeries C
Qianhai Fund of FundsSeries B Extension
Shenzhen Capital GroupSeries B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 18, 2025

    $68M round with participation from China Cinda and Real Power Capital.

  • Feb 14, 2025

    Raised $21M with Yantai Dongcheng Pharmaceutical Group participating.

Yantai Lannacheng Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Yantai Lannacheng Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Yantai Lannacheng Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersYantai
Year Founded2021
Last FundingJul 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.